Furthermore, the heightened expression of CD36 has been linked to unfavorable prognoses in metastatic breast cancer, ovarian cancer, gastric cancer, prostate cancer, and oral squamous cell carcinoma [51, 52]. The gene discussed is CD36; the disease is prostate cancer.